Xinghao Wang
ORCID: 0000-0001-8264-8537Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 10 papers. Top paper: “Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus”.
Sarthak Gupta, Michael A. Davis, Elaine Poncio, Yenealem Temesgen‐Oyelakin, Philip M. Carlucci +34 more
Michael A. Smith, Dominic Sinibaldi, Nickie Seto, Martin P. Playford, Xinghao Wang +10 more
Yenealem Temesgen‐Oyelakin, Michael A. Davis, Jun Chu, Elaine Poncio, Mohammad Naqi +27 more
Zaimin Zhu, Xinyuan Xu, Jing Sun, Li Jia, Yan Huang +10 more
Christopher B. Oliveira, Xinghao Wang, Mario Navarrete, Ana Barrera‐Vargas, Javier Merayo‐Chalico +6 more
Jorge Romo‐Tena, Xinghao Wang, Yaíma L. Lightfoot, Mariana J. Kaplan, Luz P. Blanco
Eduardo Patiño‐Martínez, Shuichiro Nakabo, Mingzeng Zhang, Hege Lynum Pedersen, Xinghao Wang +6 more
Luz P. Blanco, Carmelo Carmona‐Rivera, Shuichiro Nakabo, Hege Lynum Pedersen, Zu‐Xi Yu +2 more
Xinghao Wang, Philip M. Carlucci, Jose Jiram Torres‐Ruiz, Jorge Romo‐Tena, Hong‐Wei Sun +3 more
Xinghao Wang, Liam J. O’Neil, Shuichiro Nakabo, Kowser Hasneen, Sarthak Gupta +9 more